Repare Therapeutics Inc. Equity Securities without Readily Determinable Fair Value, Amount

Repare Therapeutics Inc. Equity Securities without Readily Determinable Fair Value, Amount

Repare Therapeutics Inc. had Equity Securities without Readily Determinable Fair Value, Amount of $1.72 million as of 2025-09-30, per its 10-Q filed 2025-11-14.

Financial Statements › Notes › Debt and Equity Securities

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2025-11-14

• 2025-09-30: Equity Securities without Readily Determinable Fair Value, Amount $1.72M.
• 2025-06-30: Equity Securities without Readily Determinable Fair Value, Amount $1.59M.
• 2024-12-31: Equity Securities without Readily Determinable Fair Value, Amount $0.00.